The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Oxytocin administration attenuates stress reactivity in borderline personality disorder: A pilot study
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kirschbaum, C., Pirke, K.-M., & Hellhammer, D. H. (2008) · Neuropsychobiology · doi:10.1159/000119004 · Cited by 6,093
Lower CSF oxytocin concentrations in women with a history of childhood abuse
Heim, C., Young, L. J., Newport, D. J., Mletzko, T., Miller, A. H., & Nemeroff, C. B. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.112 · Cited by 518
Attachment Studies with Borderline Patients: A Review
Agrawal, H. R., Gunderson, J., Holmes, B. M., & Lyons-Ruth, K. (2004) · Harvard Review of Psychiatry · doi:10.1080/10673220490447218 · Cited by 495 · cited 1×
“It is also typically characterized by insecure attachment styles, especially fearful and avoidant (Agrawal et al., 2004).”
Oxytocin enhances the experience of attachment security
Buchheim, A., Heinrichs, M., George, C., Pokorny, D., Koops, E., Henningsen, P., O’Connor, M.-F., & Gündel, H. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.04.002 · Cited by 277 · cited 2×
“It was recently shown that in healthy volunteers that a single dose of oxytocin induced a significant increase in a task-based objective measure of attachment security in insecurely attached adults (Buchheim et al., 2009).”
LEGROS, J. J., CHIODERA, P., GEENEN, V., SMITZ, S., & FRENCKELL, R. V. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-1-105 · Cited by 89
Cited by
Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688
“One recent pilot study showed a stress buffering effect of OXT in BPD patients undergoing the TSS”
BackgroundEvoked axonal oxytocin release in the central amygdala attenuates fear response
Knobloch, H. S., Charlet, A., Hoffmann, L. C., Eliava, M., Khrulev, S., Cetin, A. H., Osten, P., Schwarz, M. K., Seeburg, P. H., Stoop, R., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.030 · Cited by 1,049
The Social Salience Hypothesis of Oxytocin
Shamay-Tsoory, S. G., & Abu-Akel, A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.020 · Cited by 904
“led researchers to evaluate its therapeutic applications in various psychiatric conditions such as autism, schizophrenia and personality disorder, yielding mixed results (35-40).”
Olff, M., Frijling, J. L., Kubzansky, L. D., Bradley, B., Ellenbogen, M. A., Cardoso, C., Bartz, J. A., Yee, J. R., & van Zuiden, M. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.06.019 · Cited by 620
Self-citationBorderline personality disorder
Gunderson, J. G., Herpertz, S. C., Skodol, A. E., Torgersen, S., & Zanarini, M. C. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.29 · Cited by 470
Bakermans-Kranenburg, M. J., & van IJzendoorn, M. H. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.34 · Cited by 383
Luyten, P., & Blatt, S. J. (2013) · American Psychologist · doi:10.1037/a0032243 · Cited by 340
Intranasal Treatment of Central Nervous System Dysfunction in Humans
Chapman, C. D., Frey, W. H., Craft, S., Danielyan, L., Hallschmid, M., Schiöth, H. B., & Benedict, C. (2013) · Pharmaceutical Research · doi:10.1007/s11095-012-0915-1 · Cited by 310
De Dreu, C. K. W., & Kret, M. E. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.03.020 · Cited by 297
Prosocial effects of oxytocin and clinical evidence for its therapeutic potential
Striepens, N., Kendrick, K. M., Maier, W., & Hurlemann, R. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.07.001 · Cited by 283
“However, in a second study on 14 BPD patients compared to 13 controls a 40 IU-intranasal OXT dose yielded effects in the TSST [184].”
BackgroundInfluentialCochran, D. M., Fallon, D., Hill, M., & Frazier, J. A. (2013) · Harvard Review of Psychiatry · doi:10.1097/hrp.0b013e3182a75b7d · Cited by 267
Sharp, C., & Fonagy, P. (2015) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12449 · Cited by 237
“While no studies have been conducted in adolescents, early studies in adult BPD (Bartz et al., 2011; Simeon et al., 2011) suggest that oxytocin merits further investigation for its potential treatment implications.”
BackgroundBertsch, K., Gamer, M., Schmidt, B., Schmidinger, I., Walther, S., Kästel, T., Schnell, K., Büchel, C., Domes, G., & Herpertz, S. C. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13020263 · Cited by 214
Epigenetic regulation of the oxytocin receptor gene: implications for behavioral neuroscience
Kumsta, R., Hummel, E., Chen, F. S., & Heinrichs, M. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00083 · Cited by 207
“, 2010), borderline personality disorder (Simeon et al., 2011), and social anxiety disorder (Guastella et al.”
BackgroundReduced plasma oxytocin levels in female patients with borderline personality disorder
Bertsch, K., Schmidinger, I., Neumann, I. D., & Herpertz, S. C. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.11.013 · Cited by 189
“Correspondingly, a pilot study indicates that the intranasal administration of oxytocin may indeed attenuate the physiological and psychological response to stress in BPD (Simeon et al., 2011).”
BackgroundSocial cognition in borderline personality disorder
Roepke, S., Vater, A., Preißler, S., Heekeren, H. R., & Dziobek, I. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00195 · Cited by 184
MacDonald, K., & Feifel, D. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00035 · Cited by 181
Cardoso, C., Kingdon, D., & Ellenbogen, M. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.014 · Cited by 171
Intranasal administration of oxytocin: behavioral and clinical effects, a review
Veening, J. G., & Olivier, B. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.012 · Cited by 169
Yamasue, H., Yee, J. R., Hurlemann, R., Rilling, J. K., Chen, F. S., Meyer-Lindenberg, A., & Tost, H. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3327-12.2012 · Cited by 149
“, 2010), borderline personality disorder (Bartz et al., 2011b; Simeon et al., 2011), schizophrenia (Feifel et al.”
BackgroundLow CSF oxytocin reflects high intent in suicide attempters
Jokinen, J., Chatzittofis, A., Hellström, C., Nordström, P., Uvnäs-Moberg, K., & Åsberg, M. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.07.016 · Cited by 143
MacDonald, K., MacDonald, T. M., Brüne, M., Lamb, K., Wilson, M. P., Golshan, S., & Feifel, D. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.05.014 · Cited by 140
Oxytocin׳s role in anxiety: A critical appraisal
MacDonald, K., & Feifel, D. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.025 · Cited by 139
Oxytocin, vasopressin, and the motivational forces that drive social behaviors
Caldwell, H. K., & Albers, H. E. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_390 · Cited by 129
Oxytocin facilitates the sensation of social stress
Eckstein, M., Scheele, D., Weber, K., Stoffel‐Wagner, B., Maier, W., & Hurlemann, R. (2014) · Human Brain Mapping · doi:10.1002/hbm.22508 · Cited by 119
Sex, Receptors, and Attachment: A Review of Individual Factors Influencing Response to Oxytocin
MacDonald, K. S. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00194 · Cited by 119
Oxytocin for the treatment of drug and alcohol use disorders
Lee, M. R., & Weerts, E. M. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000258 · Cited by 105
“Most studies have used 24 IU OT (MacDonald et al., 2011), although 40 IU OT was effective in cognition and stress studies (Ditzen et al., 2009; Simeon et al., 2011; Krueger et al., 2013; Leknes et al., 2013).”
BackgroundLower Oxytocin Plasma Levels in Borderline Patients with Unresolved Attachment Representations
Jobst, A., Padberg, F., Mauer, M.-C., Daltrozzo, T., Bauriedl-Schmidt, C., Sabass, L., Sarubin, N., Falkai, P., Renneberg, B., Zill, P., et al. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00125 · Cited by 88
Oxytocin administration alters HPA reactivity in the context of parent–infant interaction
Weisman, O., Zagoory-Sharon, O., & Feldman, R. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.06.006 · Cited by 70
Frijling, J. L., van Zuiden, M., Koch, S. B. J., Nawijn, L., Veltman, D. J., & Olff, M. (2016) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsv116 · Cited by 62
Sack, M., Spieler, D., Wizelman, L., Epple, G., Stich, J., Zaba, M., & Schmidt, U. (2017) · BMC Medicine · doi:10.1186/s12916-017-0801-0 · Cited by 57
Kompier, N. F., Keysers, C., Gazzola, V., Lucassen, P. J., & Krugers, H. J. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00143 · Cited by 53
Brüne, M., Kolb, M., Ebert, A., Roser, P., & Edel, M.-A. (2015) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000240 · Cited by 35
Oxytocin and interpersonal relationships
Patin, A., Scheele, D., & Hurlemann, R. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_22 · Cited by 32
Oxytozin: Evidenz für ein therapeutisches Potenzial des sozialen Neuromodulators
Eckstein, M., & Hurlemann, R. (2013) · Der Nervenarzt · doi:10.1007/s00115-013-3832-6 · Cited by 28
Flanagan, J. C., Fischer, M. S., Nietert, P. J., Back, S. E., Maria, M. M.-S., Snead, A., & Brady, K. T. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2017.12.003 · Cited by 27
MDMA-assisted psychotherapy for borderline personality disorder
Traynor, J. M., Roberts, D. E., Ross, S., Zeifman, R., & Choi-Kain, L. (2022) · Focus · doi:10.1176/appi.focus.20220056 · Cited by 15
Metadata
- Authors
- Simeon, D., Bartz, J., Hamilton, H., Crystal, S., Braun, A., Ketay, S., & Hollander, E.
- Venue
- Psychoneuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 36
- Issue
- 9
- Pages
- 1418-1421
- ISSN
- 0306-4530 (ISSN-L)
- OpenAlex
- W2152946722
- Cited by
- 167
- References
- 5
- FWCI
- 24.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.